|
MGEA5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.909200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.576600E-01 |
| Normal-vs-Stage2 |
2.551000E-01 |
| Normal-vs-Stage3 |
2.534600E-01 |
| Normal-vs-Stage4 |
5.730200E-01 |
| Stage1-vs-Stage2 |
1.929760E-01 |
| Stage1-vs-Stage3 |
1.675830E-01 |
| Stage1-vs-Stage4 |
5.248400E-01 |
| Stage2-vs-Stage3 |
7.869600E-01 |
| Stage2-vs-Stage4 |
6.994000E-01 |
| Stage3-vs-Stage4 |
8.324600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.387200E-01 |
| Normal-vs-AfricanAmerican |
5.709600E-01 |
| Normal-vs-Asian |
5.613200E-01 |
| Caucasian-vs-AfricanAmerican |
2.994800E-01 |
| Caucasian-vs-Asian |
2.569000E-01 |
| AfricanAmerican-vs-Asian |
8.543800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.039000E-01 |
| Normal-vs-Female |
3.101800E-01 |
| Male-vs-Female |
6.098200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.530000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.208800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.187400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.737800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.266600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.979700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.625400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.367000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.576200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.101200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.04280000000368E-05 |
| Classical-VS-Follicular |
3.372600E-01 |
| Classical-VS-Other |
6.952000E-01 |
| Classical-VS-Normal |
6.531200E-01 |
| Tall-VS-Follicular |
9.481900E-03 |
| Tall-VS-Other |
1.215410E-01 |
| Tall-VS-Normal |
1.024430E-03 |
| Follicular-VS-Other |
5.490200E-01 |
| Follicular-VS-Normal |
6.188000E-01 |
| Other-VS-Normal |
6.694400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.952600E-01 |
| Normal-vs-N1 |
6.968400E-01 |
| N0-vs-N1 |
9.031600E-01 |
|
|
